Antiphospholipid syndrome induction exacerbates a transgenic Alzheimer disease model on a female background
Authors:
- Aviva KatzavAKAviva Katzav
- Achinoam Faust-SocherAFAchinoam Faust-Socher
- Filip KvapilFKFilip Kvapil
- Daniel M. MichaelsonDMDaniel M. Michaelson
- Miri BlankMBMiri Blank
- Chaim G. PickCPChaim G. Pick
- Yehuda ShoenfeldYSYehuda Shoenfeld
- Amos D. KorczynAKAmos D. Korczyn
- Joab ChapmanJCJoab Chapman
- 1 February 2011
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 32 (2) , 272-279
Abstract
No abstract availableKeywords
Funding Information
- Tel Aviv University
- Wolfson Foundation
This publication has 25 references indexed in Scilit:
- Identification of Histidine‐Rich Glycoprotein, a Potential Autoantigen, in Human and Rat Brain PreparationsAnnals of the New York Academy of Sciences, 2007
- Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002Lupus, 2003
- Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studiesLupus, 2003
- Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulantsJournal of the Neurological Sciences, 2002
- Vascular risk factors for Alzheimer’s disease:Neurobiology of Aging, 2000
- Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic miceNature Neuroscience, 1999
- Anti-β2-glycoprotein I antibodies bind to central nervous systemJournal of the Neurological Sciences, 1998
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3).Journal of Clinical Investigation, 1992
- Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndromeThe American Journal of Medicine, 1989